356 related articles for article (PubMed ID: 7530937)
1. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase.
Wolff DJ; Lubeskie A
Arch Biochem Biophys; 1995 Jan; 316(1):290-301. PubMed ID: 7530937
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of nitric oxide synthase isoforms by diaminoguanidine and NG-amino-L-arginine.
Wolff DJ; Lubeskie A
Arch Biochem Biophys; 1996 Jan; 325(2):227-34. PubMed ID: 8561501
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nitric oxide synthase isoforms by tris-malonyl-C(60)-fullerene adducts.
Wolff DJ; Papoiu AD; Mialkowski K; Richardson CF; Schuster DI; Wilson SR
Arch Biochem Biophys; 2000 Jun; 378(2):216-23. PubMed ID: 10860539
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma-inducible murine macrophage nitric oxide synthase: studies on the mechanism of inhibition by imidazole agents.
Wolff DJ; Gribin BJ
Arch Biochem Biophys; 1994 Jun; 311(2):293-9. PubMed ID: 7515612
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of nitric oxide synthase isoforms by porphyrins.
Wolff DJ; Naddelman RA; Lubeskie A; Saks DA
Arch Biochem Biophys; 1996 Sep; 333(1):27-34. PubMed ID: 8806750
[TBL] [Abstract][Full Text] [Related]
6. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases.
Reif DW; McCreedy SA
Arch Biochem Biophys; 1995 Jun; 320(1):170-6. PubMed ID: 7540822
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of the constitutive bovine endothelial nitric oxide synthase by imidazole and indazole agents.
Wolff DJ; Lubeskie A; Umansky S
Arch Biochem Biophys; 1994 Nov; 314(2):360-6. PubMed ID: 7526799
[TBL] [Abstract][Full Text] [Related]
8. Neuronal nitric oxide synthase is refractory to mechanism-based inactivation in GH3 pituitary cells.
Cooper GR; Barr A; Wolff DJ
Arch Biochem Biophys; 1998 Sep; 357(2):195-206. PubMed ID: 9735160
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of nitric oxide synthase by substituted aminoguanidines and aminoisothioureas.
Wolff DJ; Gauld DS; Neulander MJ; Southan G
J Pharmacol Exp Ther; 1997 Oct; 283(1):265-73. PubMed ID: 9336332
[TBL] [Abstract][Full Text] [Related]
10. Modulation of nitric-oxide synthase by nicotine.
Tonnessen BH; Severson SR; Hurt RD; Miller VM
J Pharmacol Exp Ther; 2000 Nov; 295(2):601-6. PubMed ID: 11046094
[TBL] [Abstract][Full Text] [Related]
11. The inhibition of the constitutive and inducible nitric oxide synthase isoforms by indazole agents.
Wolff DJ; Gribin BJ
Arch Biochem Biophys; 1994 Jun; 311(2):300-6. PubMed ID: 7515613
[TBL] [Abstract][Full Text] [Related]
12. Cellular and enzymatic studies of N(omega)-propyl-l-arginine and S-ethyl-N-[4-(trifluoromethyl)phenyl]isothiourea as reversible, slowly dissociating inhibitors selective for the neuronal nitric oxide synthase isoform.
Cooper GR; Mialkowski K; Wolff DJ
Arch Biochem Biophys; 2000 Mar; 375(1):183-94. PubMed ID: 10683266
[TBL] [Abstract][Full Text] [Related]
13. Determination of Km for oxygen of nitric oxide synthase isoforms.
Rengasamy A; Johns RA
J Pharmacol Exp Ther; 1996 Jan; 276(1):30-3. PubMed ID: 8558447
[TBL] [Abstract][Full Text] [Related]
14. Reactions catalyzed by tetrahydrobiopterin-free nitric oxide synthase.
Rusche KM; Spiering MM; Marletta MA
Biochemistry; 1998 Nov; 37(44):15503-12. PubMed ID: 9799513
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry in the identification of nitric oxide synthase isoenzymes in myocardial infarction.
Wildhirt SM; Dudek RR; Suzuki H; Pinto V; Narayan KS; Bing RJ
Cardiovasc Res; 1995 Apr; 29(4):526-31. PubMed ID: 7540956
[TBL] [Abstract][Full Text] [Related]
16. [Physiological and physiopathological aspects of nitric acid in mammalian tissues].
Molero-Leal M
Invest Clin; 1998 Jun; 39(2):125-54. PubMed ID: 9707923
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a calmodulin-dependent nitric oxide synthase from GH3 pituitary cells.
Wolff DJ; Datto GA
Biochem J; 1992 Jul; 285 ( Pt 1)(Pt 1):201-6. PubMed ID: 1379040
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of endothelial nitric oxide synthase by ebselen. Prevention by thiols suggests the inactivation by ebselen of a critical thiol essential for the catalytic activity of nitric oxide synthase.
Zembowicz A; Hatchett RJ; Radziszewski W; Gryglewski RJ
J Pharmacol Exp Ther; 1993 Dec; 267(3):1112-8. PubMed ID: 7505326
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cerebellar nitric oxide production in response to prolonged in vivo hypoxia.
Guo Y; Ward ME; Beasjours S; Mori M; Hussain SN
J Neurosci Res; 1997 Jul; 49(1):89-97. PubMed ID: 9211993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
